OGC
ABBV icon

Oak Grove Capital’s AbbVie ABBV Stock Holding History

Oak Grove Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100
Closed -$14K – 79
2021
Q4 		$14K Hold
100
– – ﹤0.01% 109
2021
Q3 		$2K Hold
100
– – ﹤0.01% 105
2021
Q2 		$2K Hold
100
– – ﹤0.01% 108
2021
Q1 		$2K Sell
100
-700
-88% -$74.9K ﹤0.01% 99
2020
Q4 		$3K Buy
+800
New +$76.9K ﹤0.01% 82
2020
Q3 		– Sell
-200
Closed -$2K – 59
2020
Q2 		$2K Buy
+200
New +$17.6K ﹤0.01% 60

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oak Grove Capital's ABBV Position: Q2 2023 in Review

Oak Grove Capital sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 2,970 shares — an estimated $473K sold.

Oak Grove Capital first reported a position in ABBV in Q1 2018 and held it in 18 quarters. The position peaked at $23.2M in Q1 2022. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • Oak Grove Capital reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • Oak Grove Capital sold 2,970 AbbVie shares in Q2 2023, an estimated $473K.
  • Oak Grove Capital first reported a position in AbbVie in Q1 2018 and held it in 18 quarters.
  • Oak Grove Capital's AbbVie position peaked at $23.2M in Q1 2022.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Oak Grove Capital's 13F filing for Q2 2023, filed 7 Aug 2023.